IMGN853
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IMGN853, covering 2022-11-21 to 2022-11-21. Get the full timeline:
Most recent: Clinical Trial Update: A Single-arm Clinical Trial of IMGN853 in Chinese Adult Patients With Platinum-resistant, Epithelial Ovarian Cancer [Phase 3]